Fresh analysis indicates that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Findings released in a major health publication demonstrates that while obese individuals often shed a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.
"Individuals buying such medications must be cognizant of the potential of rapid rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
This pace of recovery implies a return to original weight in about one and a half years.
Comparing Treatments
The research, which looked at dozens of trials involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.
The team emphasize that people who lose weight through diet and exercise typically experience a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Quick Rebound
Nutrition scientists believe the mode of action of the injections explains the amplified weight return.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of GLP-1 concentrations several times higher than normal may cause the system to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement results in hunger is unsuppressed, making overeating much more probable."
A Chronic Issue?
The NHS advise the injections for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, considering the high risk of weight regain, the treatment should be considered long-term.
This opinion is supported by drug manufacturers, who say that the findings "underscore the long-term character of obesity," similar to managing conditions like diabetes.
Patient Experiences
People who have stopped the medication report a intense resurgence of cravings.
"It was like a switch flipping and I was suddenly ravenous," described an individual.
This difficulty is exacerbated if users have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates show that millions of adults in the UK have tried these injections in the past year, with interest remaining high.
- Use is greater among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective tools for weight loss, they are not a magic cure and lasting health benefits relies on combined lifestyle management.
